PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-Feb-2023 Ophthalmic Lasers Market is expected to reach US$ 1.3 Billion at a CAGR of 5.4% by 2030 | FMI MARKITWIRED
10-Feb-2023 Ambulatory Surgical Centers Market is expected to be worth US$ 150.6 billion by 2033 | FMI MARKITWIRED
10-Feb-2023 Market Value of Total Contrast Media Injectors Sold Globally to Reach US$ 3 Billion by 2033 | FMI Reports MARKITWIRED
10-Feb-2023 Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP) Businesswire
10-Feb-2023 Axcella Therapeutics to Participate in the SVB Securities’ 2023 Global Biopharma Conference Businesswire
10-Feb-2023 MEI Pharma Reports Second Quarter Fiscal Year 2023 Results and Operational Highlights Businesswire
10-Feb-2023 Applied DNA Reports First Quarter Fiscal 2023 Financial Results Businesswire
10-Feb-2023 Rocket Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference Businesswire
09-Feb-2023 Spinal Elements® Appoints Ron Lloyd as President and Chief Executive Officer Businesswire
09-Feb-2023 Altasciences Expands Strategic Support in Europe and Adds Key Employees to Its Preclinical Team Businesswire
09-Feb-2023 Fuel Cell for Stationary Electricity Market is predicted to be valued at US$ 6 Billion by 2032 MARKITWIRED
09-Feb-2023 Vascular Patches Market is expected to reach $254 Million by 2032 MARKITWIRED
09-Feb-2023 IoT in Healthcare Market is expected to grow to nearly US$ 952.3 Billion by 2032 MARKITWIRED
09-Feb-2023 Lights for Dental Healthcare Market is expected to reach US$ 1.28 Billion by 2033 MARKITWIRED
09-Feb-2023 In Vitro Diagnostics Market is anticipated to cross a value of US$ 129.9 billion by 2033 MARKITWIRED
09-Feb-2023 Telehealth and Telemedicine Market is predicted to expand at 24% CAGR through 2033 MARKITWIRED
09-Feb-2023 Baron & Budd’s Case Against TriMark USA Remains Largest False Claims Act Recovery for Small Business Fraud Businesswire
09-Feb-2023 Basking Biosciences Presents Positive Clinical Results from Safety and Dose-Escalation Study for First Reversible Thrombolytic Agent at ISC 2023 Businesswire
09-Feb-2023 IQVIA Named to FORTUNE’s 2023 List of “World’s Most Admired Companies,” Ranked #1 in Its Category for the Second Consecutive Year Businesswire
09-Feb-2023 Oncodesign Precision Medicine Announces the Initiation of Phase I of its RIPK2 Inhibitor ODS-101, a New Therapeutic Agent for IBD Businesswire